Join the 'Flebogamma' group to help and get support from people like you.
Posted 27 Jul 2011 by Drugs.com
WEDNESDAY, July 27 – A combination therapy that "desensitizes" kidney transplant recipients could help hard-to-match patients find a needed kidney faster. The desensitization procedure combines the use of plasmapheresis – a machine that filters the blood plasma to remove antibodies – and low-doses of a medication called intravenous immune globulin (IVIG). The combination of these therapies improves survival rates dramatically. Eight years after receiving a transplant, survival rates were 81 percent for those who received the treatment compared to just 31 percent for people who had to stay on dialysis, new research found. "This is a huge unmet problem. There are probably as many as 30,000 people who have been exposed to foreign tissue waiting for a kidney. They're really hard to match," explained study author Dr. Robert Montgomery, director of the comprehensive transplant program at ... Read more
Related support groups: Renal Transplant, Gamunex, Gammagard, Immune Globulin Intravenous, Privigen, Sandoglobulin, Carimune, Octagam, Panglobulin, Gamimune N 5%, Gammaplex, Polygam S/D, Gammagard S/D, Flebogamma, Venoglobulin-S 5%, Gamimune N 10%, Panglobulin NF, Gammar-P IV, Carimune NF, Venoglobulin-S 10%
Ask a Question
Related Condition Support Groups
Autoimmune Neutropenia, Idiopathic (Immune) Thrombocytopenic Purpura, Chronic Lymphocytic Leukemia (CLL), Polymyositis / Dermatomyositis, Bone Marrow Transplantation, Evan's Syndrome, Primary Immunodeficiency Syndrome, Kawasaki Disease, HIV Infection